✦ LIBER ✦

234 POSTER NPI-0052 (a 2nd generation proteasome inhibitor) Phase 1 study in patients with lymphoma and solid tumors

✍ Scribed by R. Kurzrock; P. Hamlin; M. Gordon; D. Hong; S. Fu; A. Younes; A. Hannah; M.A. Palladino; M.A. Spear; C. Aghajanian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

236 POSTER Phase I clinical trial of the

✍ A. Townsend; P. Padrik; P. Mainwaring; T. Price; L. Catley; A. Longenecker; M.A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

1207 Results of study PX-171–007 a phase

✍ M. Gordon; J. Infante; K.P. Papadopoulos; P. Lee; E. Sausville; D. Mendelson; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

431 POSTER A phase I first-in-human stud

✍ S. Blagden; D. Olmos; R. Sharma; J. Barriuso; H. Medani; M. Versola; S. Murray; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB

383 POSTER A Phase I Study of dasatinib,

✍ J. Morgan; G. Demetri; D. Wang; I. MacPherson; P. LoRusso; A. van den Abbeele; V 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

397 POSTER A phase I dose escalation and

✍ R.A. Fleming; K.D. Holen; T.L. Cyr; B.M. Johnson; J.L.S. Gauvin; J.J. Lager; B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

651 POSTER A Phase 1 dose escalation stu

✍ L. Rosen; A. Garcia; M. Mulay; C. Cunningham; J. Nemunaitis; N. Senzer; C. Li; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 50 KB